biomedicina slovenica

pr=Čurin : 101-174

  1. Čurin-Šerbec V
    Antibodies capable to selectively detect prion Prp Sc isoforms
    2005 ►
  2. Vranac Tanja; Hafner Iva; Černilec Maja; Pretnar-Hartman Katrina; Popović Mara; Jerala Roman; Čurin-Šerbec Vladka
    The immune response against C-terminal prion protein peptide, expressed as a fusion protein
    2003 ►
  3. Černilec Maja; Vranac Tanja; Rupreht Ruth; Pretnar-Hartman Katruna; Popović Mara; Juntes Polona; Čurin-Šerbec Vladka
    No PrP-null mice are needed to obtain PrP-specific monoclonal antibodies
    2003 ►
  4. Rupreht Ruth Rebeka; Cukjati Marko; Vaupotič Tomaž; Galvani Vesna; Lukič Ljubiša; Čurin-Šerbec Vladka
    High-troughput genotyping of 193A>T (S65C), 187Cc>G (H63D) and 845G>A (C282Y) mutations in HFE gene using novel MGM probes
    2003 ►
  5. Galvani Vesna; Rupreht Ruth Rebeka; Vidan-Jeras Blanka; Čurin-Šerbec Vladka
    New real-time PCR method for PRNP gene 129 M/V codon detection (Polymorphisms in the Slovenian population)
    2003 ►
  6. Kotnik Vladimir; Ruprecht Ruth Rebeka; Mozetič-Francky Bojana; Muzlovič Igor; Čurin-Šerbec Vladka
    MIF pri bolnikih s kliničnim sumom na sepso
    [Macrophage migration inhibitory factor in patients with clinically suspected sepsis]
    2003 ►
  7. Rupreht RR; Cukjati M; Vaupotič M; Galvani V; Lukič L; Čurin-Šerbec V
    Simultaneous high-throughput genotyping of 193A>T (S65C), I87C>G (H63D) and 845G>A (C282Y) mutations in hfe gene using novel MGB probes
    2003 ►
  8. Čurin-Šerbec Vladka
    Prenosljive spongiformne encefalopatije in BSE
    [Transmissible spongiform encephalopathies and BSE]
    2002 ►
  9. Juntes P; Zabavnik-Piano J; Čurin-Šerbec V; Kovač Z; Pogačnik M
    Neuropathological lesions in the first case of bovine spongiform encephalopathy in Slovenia
    [Nevropatološke spremembe pri prvem primeru goveje spongiformne encefalopatije v Sloveniji]
    2002 ►
  10. Rupreht RR; Glonar L; Hartman-Pretnar K; Galvani V; Čurin-Šerbec V
    Diminished antigen D density not connected with sequence deviation in the coding regions of RHD gene - case report
    2002 ►
  11. Galvani V; Rupreht RR; Vidan-Jeras B; Čurin-Šerbec V
    New real-time PCR methods for PRNP gene A434G and G704A SNP detection and a study of polymorphisms in the Slovenian population
    2002 ►
  12. Rupreht RR; Hemker M; Čurin-Šerbec V; Kosec G; Pretnar-Hartman K; Maaskant van Wijk P; van der Schoot CE
    Weak D and D variants genotyping in Slovenian population
    2001 ►
  13. Kotnik Vladimir; Čurin-Šerbec V; Ihan A; Jeras M; Malovrh T; Simčič S; Škoberne M; Wraber B
    Imunologija: priročnik za vaje
    2001 ►
  14. Župec Andreja; Levičnik-Stezinar Snežna; Čurin-Šerbec Vladka; Rupreht Ruth
    Evaluation of different PCR approaches to detect TT virus sequences in Slovenian blood donors
    2001 ►
  15. Rupreht Ruth; Povodnik Natalija; Mozetič-Petruša Bojana; Čurin-Šerbec Vladka; Galvani Vesna
    Is the level of MIF a relevant prognostic factor in malignant melanoma?
    2001 ►
  16. Vranac Tanja; Alscher Maja; Pretnar-Hartman Katrina; Rupreht Ruth; Bresjanac Maja; Popović Mara; Čurin-Šerbec Vladka
    Panel of monoclonal antibodies against prion protein
    2001 ►
  17. Galvani Vesna; Rupreht Ruth; Wozniak Gordana; Popović Mara; Čurin-Šerbec Vladka
    The role of TNFalpha receptor, p55 in malignant melanoma
    2001 ►
  18. Čurin-Šerbec Vladka
    Conformation specific monoclonal antibodies against human prion protein - basis of a diagnostic assay and a tool for the research studies
    2001 ►
  19. Rupreht Ruth R; Glonar Ljerka; Čurin-Šerbec Vladka
    Molecular biology of Rhesus blood group system unusual inheritance of Rhesus antigens c and e in the Slovenian population
    2001 ►
  20. Hafner Iva; Pristovšek Primož; Vranac Tanja; Čurin-Šerbec Vladka; Jerala Roman
    Preparation and structural characterization of the recombinant C-terminal peptide fragment of human prion protein
    2001 ►
  21. Pogačnik Milan; Kovač Zoran; Juntes Polona; Čurin-Šerbec Vladka; Popović Mara
    Predvsem se mora vrniti naravna, rastlinska prehrana govedi: spongiformna encefalopatija govedi (BSE) - ali lahko Slovenija zagotovi boljšo zaščito?
    2000 ►
  22. Čurin-Šerbec V; Pretnar-Hartman K; Vranac T; Šprohar M; Popović M; Voljč B; Jung M
    Site-directed monoclonal antibody specifically recognizes PrPsc
    2000 ►
  23. Galvani V; Urbajs M; Voljč B; Kunej M; Hartman-Pretnar K; Čurin-Šerbec V; Rožman P
    Anti-FYa human monoclonal antibodies obtained from spleen
    2000 ►
  24. Galvani V; Urbajs M; Rupreht R; Dovč T; Maličev E; Čurin-Šerbec V; Rožman P
    Screening of genetic traits during lymphoblastoid transformation
    2000 ►
  25. Bojanič V; Hartman-Pretnar K; Rupreht R; Čurin-Šerbec V
    Monoclonal antibodies against tumor necrosis factor alpha (TNFalpha) and its receptors p55 (CD120a) and p75 (CD120b) in clinical diagnostics and tharapy
    1999 ►
  26. Ocvirk J; Štabuc B; Rudolf Z; Galvani V; Čurin-Šerbec V
    Serum values of tumour necrosis factor-alpha and of soluble tumour necrosis factor-R55 in melanoma patients
    2000 ►
  27. Rupreht Ruth Rebeka; Kosec Gregor; Pretnar-Hartman Katrina; Čurin-Šerbec Vladka
    Weak D and D variants genotyping in the Slovenian population
    [Genotipizacija šibkih D in D variant v slovenski populaciji]
    2000 ►
  28. Čurin-Šerbec Vladka; Pretnar-Hartman Katrina; Vranac Tanja; Rupreht Ruth; Šprohar Marjana; Juntes Polona; Popović Mara; Voljč Božidar; Jung Mirko
    Monoclonal antibodies of pre-defined specificity and their reactivity with PrP Sc
    [Monoklonska protitelesa z vnaprej določeno specifičnostjo in njihova reaktivnost do PrP Sc]
    2000 ►
  29. Rupreht Ruth Rebeka; Pretnar-Hartman Katrina; Galvani Vesna; Rožman Primož; Čurin-Šerbec Vladka
    Weak D and partial D in Slovenian population through serology and genotyping
    2000 ►
  30. Rupreht Ruth Rebeka; Mozetič-Francky Bojana; Francky Andrej; Matis Maja; Škobene Mojca; Galvani Vesna; Malovrh Tadej; Kotnik Vladimir; Čurin-Šerbec Vladka
    Murine monoclonal antibodies direct against human recombinant macrophage migration inhibitory factor
    2000 ►
  31. Galvani Vesna; Pretnar-Hartman Katrina; Rupreht Ruth R; Novaković Srdjan; Štabuc Borut; Ocvirk Janja; Menart Viktor; Gaberc-Porekar Vladimira; Štalc Anton; Rožman Primož; Čurin-Šerbec Vladka
    Soluble tumor necrosis factor receptor I (sTNFRI) as a prognostic factor in melanoma patients in Slovene population
    2000 ►
  32. Čurin-Šerbec Vladka
    Tehnike testiranja
    1995 ►
  33. Rupreht RR; Hartman-Pretnar K; Bojanič V; Rožman P; Čurin-Šerbec V
    Weak and D variants the Slovene population through serology and genotyping
    1999 ►
  34. Rupreht Ruth Rebeka; Faas Brigitte Henrica Wilhelmina; Bojanič Vesna; van Wijk Petra Anna Maaskant; Glonar Ljerka; Bricl Irena; Rožman Primož; Čurin-Šerbec Vladka
    Rhd and C/cE/e genotyping in Slovenian population
    2000 ►
  35. Grčman M; Sitar-Čurin A; Šuštar B; Vrečer F
    Study of polymorphism of 1-(4-methylsulfonylphenyl)-2-dichloroac-etamido-3-fluoro-1-propanol
    1999 ►
  36. Rupreht Ruth Rebeka; Mozetič-Francky Bojana; Francky Andrej; Matis Maja; Škoberne Mojca; Bojanič Vesna; Malovrh Tadej; Kotnik Vladimir; Čurin-Šerbec Vladka
    Murine monoclonal antibodies directed against human recombinant macrophage migration inhibitory factors
    1999 ►
  37. Bojanič Vesna; Hartman-Pretnar Katrina; Rupreht Ruth; Novaković Srdjan; Štabuc Borut; Ocvirk Janja; Menart Viktor; Gaberc-Porekar Vladka; Štalc Anton; Rožman Primož; Čurin-Šerbec Vladka
    Tumor necrosis factor (TNFA) and its soluble receptor P55 in diagnostics and therapy
    1999 ►
  38. Bojanič Vesna; Hartman-Pretnar Katrina; Rupreht Ruth; Urbajs Matjaž; Dovč Tadeja; Čurin-Šerbec Vladka; Rožman Primož
    EBV-transformed PBMCs
    1999 ►
  39. Ocvirk J; Štabuc B; Čurin V; Žumec P
    Serum TNF-alpha and soluble TNF receptors p55 in melanoma patients
    1998 ►
  40. Rupreht RR; Faas BHW; Bojanič V; Glonar L; Bricl I; Rožman P; Čurin-Šerbec V
    RhD and C/cE/e genotyping in Slovenian population
    1998 ►
  41. Sitar-Čurin Alenka; Grčman Marija; Vrečer Franc; Kotar Berta; Šuštar Božena
    Study of crystal modifications of lansoprazole using FT-IR spectroscopy and thermal analysis
    1997 ►
  42. Grčman Marija; Sitar-Čurin Alenka; Šuštar Božena; Vrečer Franc
    Study of polymorphism of 1-(4-Amino-6, 7-Dimethoxy-2-Quinazolinyl)-4-(1,4-Benzodioxan-2-Ylcarbonyl)Piperazine Mono Methanesulfonate
    1997 ►
  43. Pretnar-Hartman K; Čurin-Šerbec V
    Report of section 2A serology: anti-A, anti-B and anti-A,B reagents
    1997 ►
  44. Kožuh-Novak Mateja; Hlebec Zdravko; Stergar Eva; Dizdarević Senad; Čurin Katja; Hlebec Petra; Gašperič David; Grlica Mihaela; Kolarič Nataša; Koščak Andreja; Meško Ksaver; Mlinarič Jerica; Praprotnik Leonida; Štampar Davorin; Vojaj Sandi
    Raziskava o kvaliteti življenja na Kogu in o možnostih za turistični razvoj
    1996 ►
  45. Štabuc B; Ocvirk J; Plesničar A; Čurin V; Žunec P; Rožman P
    Increased serum levels of soluble receptor for tumours necrosis factor p-55 in melanoma patients
    1997 ►
  46. Štabuc B; Ocvirk J; Čurin V; Žunec P; Rožman P; Štalc A; Schuurbiers A; Štabuc M
    Soluble tumour necrosis factor receptor P-55 as a prognostic factor in melanoma patients
    1997 ►
  47. Čurin-Šerbec V; Žunec P; Bojanič V; Rožman P; Menart V; Štalc A; Gaberc-Porekar V; Ocvirk J; Štabuc B
    Soluble receptor of TNF-alpha, p55 as a prognostic factor in melanoma patients
    1997 ►
  48. Kotar B; Vrečer F; Merslavić M; Kramar A; Čurin A; Grčman M
    Study of polymorphism of a novel antiulcer drug
    1996 ►
  49. Grčman M; Sitar-Čurin A; Šuštar B; Vrečer F
    Study of polymorphism of 1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-((2,3-dihydro-1,4-benzodioxin-2-yl)carbonyl)-piperazine monomethanesulfonate
    1997 ►
  50. Sitar-Čurin A; Grčman M; Vrečer F; Kotar-Jordan B; Šuštar B
    Study of crystal modifications of lansoprazole using FT-IR spectroscopy, solid-state NMR spectroscopy and FT-Raman spectroscopy
    1997 ►
  51. Vrečer F; Kramar A; Čurin A; Grčman M; Kotar-Jordan B
    Study of influence of temperature and grinding on the crystalline state of lansoprazole
    1997 ►
  52. Kotnik Vladimir; Čurin-Šerbec Vladka; Ihan A; Jeras M; Simčič S; Wraber B
    Imunologija: priročnik za vaje
    1996 ►
  53. Knežević M; Alscher M; Žunec P; Rožman P; Čurin-Šerbec V
    Cultivation of mouse-mouse hybridomas producing IgM monoclonal antibodies
    1996 ►
  54. Čurin-Šerbec V
    Določanje krvnih skupin v sitemu ABO
    1996 ►
  55. Čurin-Šerbec V; Schuurbiers A; Menart V; Gaberc-Porekar V; Štalc A; Žunec P; Ocvirk J; Štabuc B
    Monoklonska protitelesa proti topnima TNF-alfa receptorjema p55 in p75 ter TNF-alfa in njegovim analogom
    1996 ►
  56. Čurin-Šerbec V
    Monoklonska protitelesa proti TNF-alfa in njegovemu analogu ter topnima receptorjema p55 in p75
    1995 ►
  57. Čurin-Šerbec V
    Monoklonska protitelesa proti antigenoma krvnega sistema AB0
    1995 ►
  58. Čurin-Šerbec V
    Imunokemijsko proučevanje strukture amoditoksina
    1988 ►
  59. Čurin-Šerbec V
    Študij toksičnega mesta na amoditoksinu A s pomočjo monoklonskih protiteles
    1991 ►
  60. Knežević M; Alscher M; Žunec P; Hartman-Pretnar K; Rožman P; Čurin-Šerbec V
    Cultivation of mouse-mouse hybridomas producing IgM monoclonal antibodies
    1996 ►
  61. Gubenšek F; Čurin-Šerbec V
    Immunological approach to the study of the structure-function relationship in neurotoxic phospholipase A2 from Vipera ammodytes venom
    1994 ►
  62. Čurin-Šerbec V; Delot E; Faure G; Saliou B; Gubenšek F; Bon C; Choumet V
    Antipeptide antibodies directed to the C-terminal part of ammodytoxin A react with the PLA2 subunit of crotoxin and neutralize its pharmacological activity
    1994 ►
  63. Harjaček M; Malenica B; Beketič L; Šimaga Š; Čurin-Šerbec V; Vitale L; Novak Ð
    Monoclonal antibodies against breast cancer antigen
    1990 ►
  64. Gubenšek F; Čurin-Šerbec V; Liang NS; Pungerčar J; Turk D
    Presynaptic toxic site in ammodytoxin
    1992 ►
  65. Čurin V; Babnik J; Kos J; Gubenšek F; Turk V
    Distribution of the EGG white cystatin in chicken
    1986 ►
  66. Čurin-Šerbec V; Kopitar N; Glonar L; Dintinjana M; Gubenšek F
    Monoclonal antibodies against antigen B of the blood system ABO
    1990 ►
  67. Skalerič U; Babnik J; Čurin V; Lah T; Turk V
    Immunochemical quantitation of cysteine proteinase inhibitor cystatin C in inflamed human gingiva
    1989 ►
  68. Kopitar-Jerala N; Čurin-Šerbec V; Jerala R; Križaj I; Gubenšek F; Turk V
    Monoclonal antibodies to human stefin B and determination of their epitopes
    1993 ►
  69. Čurin-Šerbec V; Novak D; Babnik J; Turk D; Gubenšek F
    Immunological studies of the toxic site in ammodytoxin A
    1991 ►
  70. Babnik Joža; Čurin Vladka; Lah Tamara; Turk Vito; Skalerič Uroš
    Cysteine proteinase inhibitors in inflamed human gingiva
    1988 ►
  71. Gubenšek F; Liang NS; Pungerčar J; Štrukelj B; Čurin-Šerbec V; Križaj I
    Presynaptically acting phospholipase A2 from Vipera ammodytes venom
    1994 ►
  72. Pungerčar J; Kordiš D; Jerala R; Trstenjak-Prebanda M; Dolinar M; Čurin-Šerbec V; Komel R; Gubenšek F
    Amino acid sequence of ammodytoxin C as deduced from cDNA
    1989 ►
  73. Čurin V; Babnik J; Kos J; Turk V; Gubenšek F
    "ELISA" determination of chicken cystatin in chicken
    1986 ►
  74. Babnik J; Skalerič U; Čurin V; Lah T; Turk V
    Inhibitorji cisteinskih proteinaz v vneti dlesni
    [Inhibitors of cysteine proteinase in the inflammed gingivae]
    1988 ►

   1 101

New search      Comments      Top of page Institute for Biostatistics and Medical Informatics